Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ting-shi Su"'
Autor:
Rui-Jun Zhang, Hong-Mei Zhou, Hai-Yan Lu, Hong-Ping Yu, Wei-Zhong Tang, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Ting-Shi Su, Bang-De Xiang, Mei-Ling He, Xiao-Ting Wang, Shi-Xiong Liang, Jian-Xu Li
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Purpose In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients with hepatocellular carcino
Externí odkaz:
https://doaj.org/article/57f25811182f4d709117f3acc54daa7c
Autor:
Jian-Xu Li, Wen-Xiang Deng, Shi-Ting Huang, Xiao-Feng Lin, Mei-Ying Long, Jie Zhang, Ting-Shi Su, Li-Qing Li, Ya-Dan Pang, Chun-Feng Liang, Hong-Mei Zhou, Hai-Yan Lu, Shi-Xiong Liang, Bang-De Xiang
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background The combination of transcatheter arterial chemoembolization (TACE) plus sorafenib prolonged progression-free survival (PFS) and overall survival (OS) than sorafenib or TACE monotherapy for patients with hepatocellular carcinoma (H
Externí odkaz:
https://doaj.org/article/c8e346677fe147e094030ddb3de2cf3b
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRadiation-induced lung injury (RILI) is a severe side effect of radiotherapy for non-small cell lung cancer (NSCLC) ,and one of the major hindrances to improve the efficacy of radiotherapy. Previous studies have confirmed that sodium butyra
Externí odkaz:
https://doaj.org/article/3aaefa1df71d415699b3b3c825c4b35c
Autor:
Ting-Shi Su, Qiu-Hua Liu, Xiao-Fei Zhu, Ping Liang, Shi-Xiong Liang, Lin Lai, Ying Zhou, Yong Huang, Tao Cheng, Le-Qun Li
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed
Externí odkaz:
https://doaj.org/article/e3d8be23e7654ed2b1dc981f3ca8c55d
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThe role of definitive radiotherapy in advanced esophageal squamous cell carcinoma (ESCC), especially in the metastatic setting, remains unclear. Therefore, we aimed to investigate the efficacy of chemoradiotherapy (CRT) versus chemothera
Externí odkaz:
https://doaj.org/article/7591769ccbd14b459d32c7ba7653b235
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundIn this study, we designed a new (Su’S) target area delineation to protect the normal liver during liver regeneration and prospectively evaluate liver regeneration after radiotherapy, as well as to explore the clinical factors of liver re
Externí odkaz:
https://doaj.org/article/1c67151bf25b4576883334240c6c389c
Autor:
Ting-Shi Su, Hai-Ming Yang, Ying Zhou, Yong Huang, Ping Liang, Tao Cheng, Long Chen, Le-Qun Li, Shi-Xiong Liang
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Background Child-Turcotte-Pugh (CTP) score extensively used to assess hepatic function, predicting postoperative outcome of hepatocellular carcinoma (HCC) patients. Lately, the albumin–bilirubin (ALBI) grade has been identified to be a pre
Externí odkaz:
https://doaj.org/article/f8c18ac0141740c5b8e948cec3f7bc47
Autor:
Ting-Shi Su, Li-Qing Li, Wan-Wan Meng, Yu-Dan Wang, Yi-Tian Chen, Jian-Xu Li, You-Qin Du, Song Qu, Chang Zhao, De-Jia Huang, Shi-Xiong Liang, Le-Qun Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Macroscopic vascular invasion (MVI) is a terminal manifestation of hepatocellular carcinoma (HCC) and carries an extremely poor prognosis. In Chinese and Korean HCC guidelines, transarterial chemoembolization (TACE), or/and radiotherapy (
Externí odkaz:
https://doaj.org/article/601bcbda261c4c7b93f8d642d4f54883
Autor:
Ting-Shi Su, Ping Liang, Ying Zhou, Yong Huang, Tao Cheng, Song Qu, Long Chen, Bang-De Xiang, Chang Zhao, De-Jia Huang, Shi-Xiong Liang, Le-Qun Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background and Objective: It is unclear if stereotactic body radiation therapy (SBRT) or transarterial chemoembolization (TACE) is better for the treatment of inoperable early-stage hepatocellular carcinoma (HCC). This study aimed to retrospectively
Externí odkaz:
https://doaj.org/article/d0782eaebbc14aa48f6aee32a8302b64
Autor:
Ping Liang, Shi-Xiong Liang, Ying Zhou, Lin Lai, Tao Cheng, Xiaofei Zhu, Qiu-Hua Liu, Le-Qun Li, Ting-Shi Su, Yong Huang
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85edded93565e0ed853013d75b2fdbe1
https://doaj.org/article/e3d8be23e7654ed2b1dc981f3ca8c55d
https://doaj.org/article/e3d8be23e7654ed2b1dc981f3ca8c55d